Actavis posts 35% production profit margin

Iceland-based Actavis producer, which took over the Sindan factory in 2006, posted a 35 percent profit margin in 2007, the highest of all local producers. Actavis is specialized in cancer treatments. In 2006, Sindan’s profit margin was 22.9 percent.

Actavis posted turnover in 2007 worth €13.9 million for production activities, compared to €11.3 mln year-on-year. The company has 137 employees on the production segment.

Another local producer, Antibiotice Iasi, had a 14 percent profit margin and business worth €68.8 million. The company is the largest local employer, with personnel totaling 1,565 people.

Producer Terapia-Ranbaxy, which has a factory with 1,026 employees, posted business worth €88 mln and profit amounting to €11.7 mln, leading to a 13 percent profit margin.

Other local producers registered profit margins below 10 percent. The most significant losses were registered by the local branch of Hungarian Gedeon Richter’s production division, at €1 million. The company’s business amounted to €18.7 mln, leading to a 5.4 percent loss margin.

The local pharmaceutical market is worth some €1.85 mln and is expected to increase by 8 percent this year, lower than previous years, according to Cegedim research company.